Efficacy and safety of secukinumab in juvenile idiopathic arthritis Presented ByDr Nicola Ruperto, IRCCS Istituto G. Gaslini, Italy TrialPhase 3, JUNIPERA ConferenceEULAR 2021 TypePeer-reviewed article 2 August 2021 23:33